Compassionate Use of Ubamatamab

Regeneron Pharmaceuticals

Overview

Provide Compassionate Use of Ubamatamab

Compassionate Use requests are only being considered in response to Individual Patient Investigational New Drug (IND) applications.

Study Type

EXPANDED_ACCESS

Medical Language ↔ Plain English

Eligibility will be determined during the application review process.

Requests for compassionate use must be initiated by a treating physician Physicians should contact

CONTACT

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.